JACQUES JM
VAN DONGEN
Investigador
VU University Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de VU University Medical Center (11)
2018
-
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Neuro-Oncology, Vol. 20, Núm. 11, pp. 1494-1504
2016
-
Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: Study ALL10 from the Dutch Childhood Oncology Group
Journal of Clinical Oncology, Vol. 34, Núm. 22, pp. 2591-2601
2013
-
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
Leukemia
-
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation
Leukemia, Vol. 27, Núm. 7, pp. 1497-1503
2011
2010
-
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
Leukemia, Vol. 24, Núm. 9, pp. 1599-1606
-
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
Leukemia, Vol. 24, Núm. 7, pp. 1258-1264
1998
1991
1990
-
Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development
Leukemia, Vol. 4, Núm. 5, pp. 383-389
1987
-
Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis
Journal of Neuroimmunology, Vol. 15, Núm. 3, pp. 243-249